HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jan Tennvall Selected Research
Jan Tennvall Research Topics
Disease
29
Neoplasms (Cancer)
10/2022 - 01/2002
10
Carcinoma (Carcinomatosis)
12/2015 - 06/2011
10
Neoplasm Metastasis (Metastasis)
08/2014 - 02/2003
6
B-Cell Lymphoma (Lymphoma, B Cell)
04/2007 - 01/2002
5
Body Weight (Weight, Body)
01/2015 - 02/2010
4
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 02/2010
3
Thyroid Neoplasms (Thyroid Cancer)
10/2022 - 05/2006
3
Lymphoma (Lymphomas)
05/2006 - 09/2003
3
Squamous Cell Carcinoma of Head and Neck
12/2004 - 02/2002
2
Pain (Aches)
03/2013 - 07/2007
2
Prostatic Neoplasms (Prostate Cancer)
03/2013 - 07/2007
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2007 - 07/2005
1
Dermatitis
10/2022
1
Graves Disease (Basedow Disease)
04/2019
1
Weight Loss (Weight Reduction)
04/2013
1
Second Primary Neoplasms (Neoplasms, Second)
03/2013
1
Bone Diseases (Bone Disease)
03/2013
1
Fatigue
09/2012
1
Asthenia
09/2012
1
Pneumonia (Pneumonitis)
09/2012
1
Colonic Neoplasms (Colon Cancer)
02/2010
1
Neuroblastoma
09/2009
1
Synovitis
05/2006
1
Hyperthyroidism
05/2006
1
Liver Neoplasms (Liver Cancer)
05/2006
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2005
1
Chromosome Aberrations (Chromosome Abnormalities)
12/2004
1
Breast Neoplasms (Breast Cancer)
01/2002
Drug/Important Bio-Agent (IBA)
11
Radioisotopes (Radionuclides)
IBA
01/2022 - 02/2003
11
Monoclonal Antibodies
IBA
12/2015 - 01/2005
7
Immunoconjugates (Immunoconjugate)
IBA
01/2015 - 10/2005
5
Antibodies
IBA
04/2019 - 06/2007
4
Antigens
IBA
01/2015 - 02/2010
3
lutetium Lu 177 dotatate
IBA
01/2022 - 01/2021
3
BR96 monoclonal antibody
IBA
08/2014 - 10/2005
3
Therapeutic Uses
IBA
08/2013 - 02/2010
2
Iodine
IBA
10/2022 - 05/2006
2
Lutetium-177
IBA
08/2014 - 04/2012
2
Lewis Y antigen
IBA
08/2013 - 04/2013
2
Radium-223
IBA
03/2013 - 07/2007
2
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
IBA
09/2007 - 07/2005
2
Rituximab (Mabthera)
FDA Link
04/2007 - 08/2005
2
epratuzumab
IBA
07/2005 - 09/2003
1
AZD 6244
IBA
10/2022
1
Somatostatin Receptors (Somatostatin Receptor)
IBA
01/2022
1
Thyrotropin Receptors (Thyrotropin Receptor)
IBA
04/2019
1
Reducing Agents
IBA
08/2014
1
Astatine-211
IBA
08/2014
1
Halogens
IBA
08/2014
1
Silicon
IBA
08/2013
1
Chlorides
IBA
03/2013
1
vandetanib (ZD6474)
IBA
09/2012
1
auristatin
IBA
02/2010
1
Creatinine
IBA
02/2010
1
Lutetium
IBA
02/2010
1
Yttrium
IBA
02/2010
1
Biotin (Vitamin H)
FDA Link
02/2010
1
Acids
IBA
02/2010
1
Streptavidin
IBA
09/2007
1
Hormones (Hormone)
IBA
07/2007
1
ibritumomab tiuxetan (Zevalin)
FDA Link
04/2007
1
Ethiodized Oil (Ethiodol)
FDA Link
05/2006
1
3-Iodobenzylguanidine (Iobenguane)
IBA
05/2006
1
Peptides (Polypeptides)
IBA
05/2006
1
Proteins (Proteins, Gene)
FDA Link
07/2005
1
Cisplatin (Platino)
FDA Link
Generic
12/2004
1
DNA (Deoxyribonucleic Acid)
IBA
08/2004
1
A-factor (Streptomyces)
IBA
09/2003
1
Trastuzumab (Herceptin)
FDA Link
01/2002
1
Cytostatic Agents
IBA
01/2002
Therapy/Procedure
15
Radioimmunotherapy
12/2015 - 01/2002
12
Therapeutics
01/2022 - 02/2002
4
Aftercare (After-Treatment)
05/2014 - 03/2012
4
Radiotherapy
03/2013 - 02/2003
3
Immunotherapy
09/2009 - 05/2006
2
Drug Therapy (Chemotherapy)
07/2011 - 01/2002
1
Castration
03/2013
1
Injections
03/2013
1
Transplantation
09/2009
1
Stem Cell Transplantation
09/2009
1
Intravenous Injections
07/2007
1
Lasers (Laser)
06/2007
1
Gamma Cameras (Gamma Camera)
02/2007
1
Microspheres (Microsphere)
05/2006
1
Neoadjuvant Therapy
01/2002